Spontaneous mutation frequency and molecular mechanisms of Shigella flexneri fluoroquinolone resistance under antibiotic selective stress
- 452 Downloads
- 6 Citations
Abstract
The incidence of fluoroquinolone-resistant Shigella strains has risen rapidly, presumably in response to ciprofloxacin antibiotic stress. Understanding the molecular mechanisms underlying this resistance phenotype is critical to developing novel and effective therapeutic strategies. In this study, the frequency of ciprofloxacin-induced mutation was measured in antibiotic resistance genes (gyrA, gyrB, parC, parE, marOR, and marA) of Shigella flexneri. The S. flexneri 2a strain 301 was cultured on Luria–Bertani agar plates containing one of seven different ciprofloxacin concentrations (range: 0.03125–2 μg mL−1). Resistant colonies were selected for gene-targeted sequencing analysis; the identified point mutations were subsequently confirmed by insertion into antibiotic cassette plasmids and growth under ciprofloxacin stress. The results demonstrated that the seven different ciprofloxacin concentrations produced dose-dependent frequencies of spontaneous mutations: 10−8 (0.03125 and 0.0625 μg mL−1), 10−9 (0.125 μg mL−1), and <10−9 (0.25, 0.5, 1, 2 μg mL−1). PCR sequencing of the ten randomly selected resistant colonies (minimum inhibitory concentrations (MICs) of 0.125 μg mL−1, n = 5 and 0.25 μg mL−1, n = 5) revealed that all colonies had mutations in the gyrA gene at either codon 83 (Ser83 → Leu) or 87 (Asp87 → Tyr or → Gly), both of which were confirmed at MIC of 0.125 μg mL−1. None of the spontaneous mutation colonies exhibited gyrB, parC, parE, marOR, or marA mutations. In conclusion, S. flexneri is normomutable under ciprofloxacin antibiotic stress and fluoroquinolone resistance by spontaneous mutation occurs at a low rate. Codon mutations gyrA 83 and/or gyrA 87 cause a 4-fold increase in the ciprofloxacin MIC, and may represent the natural mechanism of fluoroquinolone resistance.
Keywords
Antibiotic resistance Spontaneous mutation Shigella gyrA point mutation FluoroquinoloneNotes
Acknowledgments
This work was supported by grants from Zhejiang Provincial Natural Science Foundation of China (No. LQ12H19001), the Zhejiang Municipal Bureau of Health (No. 2009A177), and the Bureau of Hangzhou City Science and Technology Project of Zhejiang Province (No. 20110733Q05).
References
- Ahmed AM, Furuta K, Shimomura K, Kasama Y, Shimamoto T (2006) Genetic characterization of multidrug resistance in Shigella spp. from Japan. J Med Microbiol 55:1685–1691CrossRefGoogle Scholar
- AI-Nimri S, Miller WA, Byrne BA, Guibert G, Chen L (2009) A unified approach to molecular epidemiology investigations: tools and patterns in California as a case study for endemic shigellosis. BMC Infect Dis 9:184CrossRefGoogle Scholar
- Baquero MR, Nilsson AI, Turrientes MC, Sandvang D, Galán JC, Martínez JL, Frimodt-Møller N, Baquero F, Andersson DI (2004) Polymorphic mutation frequencies in Escherichia coli: emergence of weak mutator in clinical isolates. J Bacteriol 186:5538–5542CrossRefGoogle Scholar
- Cold Spring Harbor Laboratory Press (2002) Molecular cloning (Third Edition)Google Scholar
- Dutta S, Kawamura Y, Ezaki T, Nair GB, Iida K, Yoshida S (2005) Alteration in the gyrA subunit of DNA gyrase and the parC subunit of topoisomerase IV in quinolone-resistant Shigella dysenteriaee serotype 1 clinical isolates from Kolkata, India. Antimicrob Agents Chemother 49:1660–1661CrossRefGoogle Scholar
- Eick S, Schmitt A, Sachse S, Schmidt KH, Pfister W (2004) In vitro antibacterial activity of fluoroquinolones against Porphyromonas gingivalis strains. J Antimicrob Chemother 54:553–556CrossRefGoogle Scholar
- Folster JP, Pecic G, Bowen A, Rickert R, Carattoli A, Whichard JM (2011) Decreased susceptibility to ciprofloxacin among Shigella isolates in the United States, 2006 to 2009. Antimicrob Agents Chemother 55:1758–1760CrossRefGoogle Scholar
- Hanninen ML, Hannula M (2007) Spontaneous mutation frequency and emergence of ciprofloxacin resistance in Campylobacter jejuni and Campylobacter coli. J Antimicrob Chemother 60:1251–1257CrossRefGoogle Scholar
- Hu LF, Li JB, Ye Y, Li X (2007) Mutations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in clinical strains of fluoroquinolone-resistant Shigella in Anhui, China. J Microbiol 45:168–170Google Scholar
- Jeon B, Muraoka W, Sahin O, Zhang Q (2008) Role of Cj1211 in natural transformation and transfer of antibiotic resistance determinants in Campylobacter jejuni. Antimicrob Agents Chemother 52:2699–2708CrossRefGoogle Scholar
- Jeon B MuraokaW, Scupham A, Zhang Q (2009) Roles of lipooligosaccharide and capsular polysaccharidein antimicrobial resistance and natural transformation of Campylobacter jejuni. J Antimicrob Chemother 63:462–468Google Scholar
- Jin Q, Yuan Z, Wang Y, Shen Y, Lu W, Wang J, Liu H, Yang J, Yang F et al (2002) Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of Escherichia coli K12 and O157. Nucleic Acides Res 30:4432–4441CrossRefGoogle Scholar
- Kim JY, Kim SH, Jeon SM, Park MS, Rhie HG, Lee BK (2008) Resistance to fluoroquinolones by the combination of target site mutations and enhanced expression of genes for efflux pumps in Shigella flexneri and Shigella sonnei strains isolated in Korea. Clin Microbiol Infect 14:760–765CrossRefGoogle Scholar
- Martinez JL, Baquero F (2000) Mutation frequencies and antibiotic resistance. Antimicrob Agents Chemother 44:1771–1777CrossRefGoogle Scholar
- Pazhani GP, Niyogi SK, Singh AK, Sen B, Taneja N, Kundu M, Yamasaki S, Ramamurthy T (2008) Molecular characterization of multidrug-resistant Shigella species isolated from epidemic and endemic cases of shigellosis in India. J Med Microbiol 57:856–863CrossRefGoogle Scholar
- Pu XY, Pan JC, Wang HQ, Zhang W, Huang ZC, Gu YM (2009) Characterization of fluoroquinolone-resistant Shigella flexneri in Hangzhou area of China. J Antimicrob Chemother 63:917–920CrossRefGoogle Scholar
- Ren JC, Duan GC, Song CH, Lu RL, Zhang WD, Xi YL (2010) The detection of marOR mutations and their relations with acrAB-tolC expression. China J Microbiol Immunol 30:201–204Google Scholar
- Rodriguez-Martinez JM, Cano ME, Velasco C, Martínez-Martínez L, Pascual A (2011) Plasmid-mediated quinolone resistance: an update. J Infect Chemother 17:149–182CrossRefGoogle Scholar
- Shen Z, Pu XY, Zhang Q (2011) Salicylate functions as an efflux pump inducer and promotes the emergence of fluoroquinolone-resistant Campylobacter jejuni mutants. Appl Environ Microbiol 77:7128–7133CrossRefGoogle Scholar
- Song C (2007) Study on the molecular mechanism of multi-drug resistance in Shieglla spp. Ph. D thesis. College of Public Health of Zhengzhou University, ChinaGoogle Scholar
- Wang G, Wilson TJ, Jiang Q, Taylor DE (2001) Spontaneous mutations that confer antibiotic resistance in Helicobacter pylori. Antimicrob Agents Chemother 45:727–733CrossRefGoogle Scholar
- WHO (2004) International note on antibiotics in the management of shigellsosis [J]. Wkly Epidemiol Rec 79:202–203Google Scholar
- Zirnstein G, LiY Swaminathan B, Angulo F (1999) Ciprofloxacin resistance in Campylobacter jejuni isolates: detection of gyrA resistance mutations by mismatch amplification mutation assay PCR and DNA sequence analysis. J Clin Microbiol 37:3276–3278Google Scholar